InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

HALOZYME THERAPEUTICS, INC.

HALO Clue Score52
United States Fiscal year ends December CIK 0001159036
$110.42 +0.53% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $110.42 +196.67% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue146.7Operating income−83.2Net income−103.0EPS, diluted−0.81Fiscal year 2017Revenue316.6 +115.8%Operating income81.0Net income63.0EPS, diluted0.45Fiscal year 2018Revenue151.9 −52.0%Operating income−69.3Net income−80.3 −227.6%EPS, diluted−0.56 −224.4%Fiscal year 2019Revenue196.0 +29.1%Operating income−67.6Net income−72.2EPS, diluted−0.50Fiscal year 2020Revenue267.6 +36.5%Operating income144.3Net income129.1EPS, diluted0.91Fiscal year 2021Revenue443.3 +65.7%Operating income275.9Net income402.7 +212.0%EPS, diluted2.74 +201.1%Fiscal year 2022Revenue660.1 +48.9%Operating income267.5Net income202.1 −49.8%EPS, diluted1.44 −47.4%Fiscal year 2023Revenue829.3 +25.6%Operating income337.6Net income281.6 +39.3%EPS, diluted2.10 +45.8%Fiscal year 2024Revenue1,015.3 +22.4%Operating income551.5Net income444.1 +57.7%EPS, diluted3.43 +63.3%Fiscal year 2025Revenue1,396.6 +37.6%Operating income469.0Net income316.9 −28.6%EPS, diluted2.56 −25.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 146.7 316.6 151.9 196.0 267.6 443.3 660.1 829.3 1,015.3 1,396.6
Growth +115.8% −52.0% +29.1% +36.5% +65.7% +48.9% +25.6% +22.4% +37.6%
Operating income −83.2 81.0 −69.3 −67.6 144.3 275.9 267.5 337.6 551.5 469.0
Net income −103.0 63.0 −80.3 −72.2 129.1 402.7 202.1 281.6 444.1 316.9
Growth −227.6% +212.0% −49.8% +39.3% +57.7% −28.6%
EPS, diluted −0.81 0.45 −0.56 −0.50 0.91 2.74 1.44 2.10 3.43 2.56
Growth −224.4% +201.1% −47.4% +45.8% +63.3% −25.4%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−56.7%Net margin−70.2%Free cash flow margin−36.5%Fiscal year 2017Operating margin25.6%Net margin19.9%Free cash flow margin41.9%Fiscal year 2018Operating margin−45.7%Net margin−52.9%Free cash flow margin−35.7%Fiscal year 2019Operating margin−34.5%Net margin−36.9%Free cash flow margin−45.6%Fiscal year 2020Operating margin53.9%Net margin48.2%Free cash flow margin19.8%Fiscal year 2021Operating margin62.2%Net margin90.8%Free cash flow margin67.2%Fiscal year 2022Operating margin40.5%Net margin30.6%Free cash flow margin35.6%Fiscal year 2023Operating margin40.7%Net margin34.0%Free cash flow margin45.0%Fiscal year 2024Operating margin54.3%Net margin43.7%Free cash flow margin46.1%Fiscal year 2025Operating margin33.6%Net margin22.7%Free cash flow margin46.2%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −56.7% 25.6% −45.7% −34.5% 53.9% 62.2% 40.5% 40.7% 54.3% 33.6%
Net margin −70.2% 19.9% −52.9% −36.9% 48.2% 90.8% 30.6% 34.0% 43.7% 22.7%
Free cash flow margin −36.5% 41.9% −35.7% −45.6% 19.8% 67.2% 35.6% 45.0% 46.1% 46.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−50.4Capital expenditure−3.1Free cash flow−53.5Fiscal year 2017Operating cash flow134.1Capital expenditure−1.4Free cash flow132.7Buybacks0.0Fiscal year 2018Operating cash flow−49.5Capital expenditure−4.7Free cash flow−54.2 −140.8%Buybacks0.0Fiscal year 2019Operating cash flow−85.4Capital expenditure−4.0Free cash flow−89.5Buybacks−200.0Fiscal year 2020Operating cash flow55.5Capital expenditure−2.5Free cash flow53.0Buybacks−150.1Fiscal year 2021Operating cash flow299.4Capital expenditure−1.5Free cash flow298.0 +462.8%Buybacks−350.1Fiscal year 2022Operating cash flow240.1Capital expenditure−4.8Free cash flow235.3 −21.0%Buybacks−200.0Fiscal year 2023Operating cash flow388.6Capital expenditure−15.3Free cash flow373.3 +58.6%Buybacks−402.4Fiscal year 2024Operating cash flow479.1Capital expenditure−10.7Free cash flow468.4 +25.5%Buybacks−250.0Fiscal year 2025Operating cash flow651.6Capital expenditure−7.0Free cash flow644.6 +37.6%Buybacks−342.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −50.4 134.1 −49.5 −85.4 55.5 299.4 240.1 388.6 479.1 651.6
Capital expenditure −3.1 −1.4 −4.7 −4.0 −2.5 −1.5 −4.8 −15.3 −10.7 −7.0
Free cash flow −53.5 132.7 −54.2 −89.5 53.0 298.0 235.3 373.3 468.4 644.6
Growth −140.8% +462.8% −21.0% +58.6% +25.5% +37.6%
Buybacks n/a 0.0 0.0 −200.0 −150.1 −350.1 −200.0 −402.4 −250.0 −342.4

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash66.8Total debt216.6Net cash (debt)−149.9Shareholders’ equity−32.5Fiscal year 2017Cash168.7Total debt202.4Net cash (debt)−33.6Shareholders’ equity208.4Debt to equity0.97Fiscal year 2018Cash57.9Total debt126.4Net cash (debt)−68.4Shareholders’ equity248.9Debt to equity0.51Fiscal year 2019Cash120.2Total debt402.6Net cash (debt)−282.4Shareholders’ equity91.8Debt to equity4.39Fiscal year 2020Cash147.7Total debt397.2Net cash (debt)−249.5Shareholders’ equity151.0Debt to equity2.63Fiscal year 2021Cash118.7Total debt876.7Net cash (debt)−758.0Shareholders’ equity197.0Debt to equity4.45Fiscal year 2022Cash234.2Total debt1,506.1Net cash (debt)−1,271.9Shareholders’ equity169.8Debt to equity8.87Fiscal year 2023Cash118.4Total debt1,499.2Net cash (debt)−1,380.9Shareholders’ equity83.8Debt to equity17.89Fiscal year 2024Cash115.9Total debt1,505.8Net cash (debt)−1,389.9Shareholders’ equity363.8Debt to equity4.14Fiscal year 2025Cash133.8Total debt2,142.6Net cash (debt)−2,008.8Shareholders’ equity48.8Debt to equity43.89
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 66.8 168.7 57.9 120.2 147.7 118.7 234.2 118.4 115.9 133.8
Total debt 216.6 202.4 126.4 402.6 397.2 876.7 1,506.1 1,499.2 1,505.8 2,142.6
Net cash (debt) −149.9 −33.6 −68.4 −282.4 −249.5 −758.0 −1,271.9 −1,380.9 −1,389.9 −2,008.8
Shareholders’ equity −32.5 208.4 248.9 91.8 151.0 197.0 169.8 83.8 363.8 48.8
Debt to equity n/a 0.97 0.51 4.39 2.63 4.45 8.87 17.89 4.14 43.89

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−50.4 134.1 −49.5 −85.4 55.5 299.4 240.1 388.6 479.1 651.6
Growth −136.9% +440.0% −19.8% +61.8% +23.3% +36.0%
2.4 2.2 2.4 4.1 3.3 3.0 6.5 11.1 10.3 11.4
Investment
−3.1 −1.4 −4.7 −4.0 −2.5 −1.5 −4.8 −15.3 −10.7 −7.0
calc −53.5 132.7 −54.2 −89.5 53.0 298.0 235.3 373.3 468.4 644.6
Growth −140.8% +462.8% −21.0% +58.6% +25.5% +37.6%
calc −0.42 0.95 −0.38 −0.62 0.37 2.03 1.67 2.78 3.62 5.20
−76.8 −163.7 2.5 −5.5 78.4 −406.3 −487.0 −96.9 −262.7 −545.8
Financing
150.6 131.7 −63.8 153.2 −106.3 77.9 362.4 −408.0 −218.9 −85.2
n/a 0.0 0.0 −200.0 −150.1 −350.1 −200.0 −402.4 −250.0 −342.4

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.